Arnnon Geshuri - 25 Mar 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
25 Mar 2024
Net transactions value
-$92,475
Form type
4
Filing time
26 Mar 2024, 16:05:13 UTC
Previous filing
20 Mar 2024
Next filing
04 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise $20,475 +7,500 +19% $2.73 45,970 25 Mar 2024 Direct F1
transaction TDOC Common Stock Sale $112,950 -7,500 -16% $15.06 38,470 25 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Employee Stock Option (right to buy) Options Exercise $0 -7,500 -3.3% $0.000000 220,278 25 Mar 2024 Common Stock 7,500 $2.73 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 8, 2023.
F2 One-fourth of the option vested on December 4, 2018 and 1/48 of the option vests monthly thereafter.